Format

Send to

Choose Destination
J Cataract Refract Surg. 2007 Mar;33(3):516-21.

Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A.

Author information

1
Department of Ophthalmology, Vivantes-Klinikum Neukölln, Berlin, Germany. gwollens@hotmail.com

Abstract

PURPOSE:

To examine the influence of a new crosslinking treatment on corneal swelling properties that correlate with the degree of crosslinking.

SETTING:

Department of Ophthalmology, Vivantes-Klinikum Neukölln, Berlin, Germany.

METHODS:

Twenty freshly enucleated porcine eyes were crosslinked by applying the photosensitizer riboflavin and ultraviolet-A (UVA) light (370 nm, 3 mW/cm2) for 30 minutes. After the eyes were treated and incubated for 24 hours in a moist chamber, 15 eyes were examined by biomicroscopy and optical coherence tomography (OCT); 5 eyes were examined by light microscopy. Five control eyes were included.

RESULTS:

Using light microscopy, a characteristic swelling pattern with 3 zones was identified in the crosslinked porcine cornea: an anterior intensely crosslinked zone of 242 microm, an intermediate partially crosslinked zone of 238 microm (hydration factor 2.2), and a noncrosslinked posterior zone of 1355 microm (hydration factor 2.7). A condensed OCT signal was demonstrated in the treated portion of the anterior stroma to a depth of 520 microm with a pronounced line at 540 microm, correlating with the combined anterior and intermediate layers after hydration in the histological analysis. In the nonhydrated state of the crosslinked cornea, the anterior zone was deduced to be 242 microm; the intermediate zone, 109 microm; and the posterior zone, 501 microm. Therefore, the maximum depth of the crosslinking effect was 351 microm.

CONCLUSIONS:

Collagen crosslinking using riboflavin and UVA led to a significant change in the swelling behavior of the anterior stroma, confirming prior findings that the crosslinking effect is strongest in the anterior half of the stroma. Crosslinked cornea did not induce a specific signal on OCT, and OCT is therefore not suited for clinical controls of the crosslinking effect.

PMID:
17321404
DOI:
10.1016/j.jcrs.2006.11.015
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center